Effect of Oral Sildenafil Citrate on Improvement of Endometrial Thickness
Status:
Completed
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
One hundred thirty women with unexplained infertility participated in a prospective clinical
study. Patients were assigned at random to one of two groups. The first group (n=65) served
as the study group and was given clomiphene citrate 50 mg (Tecnovula®, Techno
Pharmaceuticals, Egypt) and sildenafil (Respatio®, Pharma right group, Egypt) 20 mg tablets.
The second group (n=65) served as a control and received a placebo tablet in addition to the
standard treatment of clomiphene citrate 50 mg (Tecnovula®). A transvaginal ultrasound was
performed on all of the patients to assess ovulation.